← Explore

Piezo1 Mediates Ultrasound-Stimulated Dopaminergic Neuron Protection via Synaptic Vesicle Recycling and Ferroptosis Inhibition

Tian Xu, Li Zhang, Xiaoxiao Lu, Wei Ji, Kaidong Chen

Neuroscience Bulletin 2025 · 10.1007/s12264-025-01420-5

in vitro cellrodentparkinsons diseaseinvasive electrophysiologyhistology molecularbehaviourother

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the aggregation of α-synuclein (α-syn) and dysregulated synaptic vesicle (SV) recycling. Emerging evidence suggests that ferroptosis is the target of PD therapy. However, the identification of effective anti-ferroptosis treatments remains elusive. This study explores the therapeutic potential of low-intensity ultrasound (US) in modulating SV recycling and anti-ferroptosis in cellular and animal models of PD. We demonstrate that optimized US stimulation (610 kHz, 0.2 W/cm 2 ) activates Piezo1 channel-mediated fast endophilin-mediated endocytosis, which promotes SV recycling and synaptic function, presenting with increased frequency and amplitude of both spontaneous excitatory synaptic currents and miniature excitatory postsynaptic currents. Repaired SV recycling in turn reduces the accumulation of α-syn expression and ferroptotic cell death. These findings support the potential of noninvasive ultrasonic neuromodulation as a therapeutic strategy for PD and lead to meaningful health outcomes for the aging population.

Abstract via europepmc.

Specieshuman (SH-SY5Y cell line); mouse (C57BL/6)
Subjectsnot reported animals
Sessions per subject7
Randomisedyes
Blindingnot reported
Sham / controlno treatment control
Auditory controlnot reported
Readout timingoffline
Anaesthesiaanaesthetised
Readoutsinvasive electrophysiology, histology molecular, behaviour, other — Patch-clamp mEPSC/sEPSC; Western blot (GPX4, alpha-synuclein); flow cytometry (iron, lipid peroxidation, Ca2+); electron microscopy; immunofluorescence; ELISA and HPLC dopamine; open field and pole test
Direction of effectexcitatoryUS at 610 kHz and 0.2 W/cm2 increased frequency and amplitude of mEPSCs and sEPSCs, restored synaptic vesicle recycling and reduced ferroptosis markers in MPP+ cells and MPTP mice; effects were blocked by the Piezo1 inhibitor GsMTx4.
Adverse eventsnone observedBehavioral tests were conducted one week after the final injection and again following the treatment. No unexpected adverse events occurred.

Exposures

Exposure 1: SH-SY5Y PD cell model, continuous US at 610, 746 and 1000 kHz

Target: cultured neurons — “differentiated SH-SY5Y cells (MPP+ PD model)”
Device: other named manufacturer · Jiangsu Hanmei Science and Technology Co., Ltd · HM-1 therapeutic device ✓

Pulse timing
Waveformcontinuous
Fundamental frequency (kHz)610, 746, 1,000swept✓✓✓
Pulse duration (ms)not applicable
Pulse repetition frequency (Hz)not applicable
Duty cycle (%)not applicable⚑
Sonication duration (s)40✓✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot applicable
In-situ pressure (kPa)not applicable
In-situ Isppa (W/cm²)not applicable
In-situ Ispta (W/cm²)not applicable
Ispta, domain unspecified (W/cm²)0.1, 0.3swept✓?⚑
Protocol, in the paper’s words

Continuous US applied to cells in plates for 40 s per well at three frequencies and graded intensities; optimum 610 kHz and 0.20 W/cm2.

Exposure 2: MPTP mice, 610 kHz 0.2 W/cm2 daily for 7 days

Target: brain — “head, where US transducers were located (striatum analysed)”
Device: other named manufacturer · Jiangsu Hanmei Science and Technology Co., Ltd · HM-1 therapeutic device ✓

Pulse timing
Waveformcontinuous
Fundamental frequency (kHz)610✓✓✓
Pulse duration (ms)not applicable
Pulse repetition frequency (Hz)not applicable
Duty cycle (%)not applicable
Sonication duration (s)900✓✓✓
Pressure and intensity, by domain
Free-field pressure (kPa)not reported
Free-field Isppa (W/cm²)not reported
Free-field Ispta (W/cm²)not reported
In-situ estimatenot reported
In-situ pressure (kPa)not reported
In-situ Isppa (W/cm²)not reported
In-situ Ispta (W/cm²)not reported
Ispta, domain unspecified (W/cm²)0.2✓?⚑
Protocol, in the paper’s words

Daily 15-min US stimulation at 610 kHz and 0.2 W/cm2 for 7 days under isoflurane anaesthesia; target position on head not stated.

Flags from extraction

  • exposures[0].unspecified_domain.ispta_w_cm2 — Paper says only 'intensity' measured with a US power meter before sonication; whether spatial-peak temporal-average and in which medium is not stated. Results text gives 0.05 to 0.25 W/cm2 for the same sweep while Methods give 0.1 to 0.3 W/cm2.
  • exposures[1].unspecified_domain.ispta_w_cm2 — Intensity type and domain not stated; placed in unspecified_domain.
  • n_subjects — Forty mice in four groups of about ten; only the PD+US and PD+US+GsMTx4 groups were sonicated. Cell experiments not counted.
  • exposures[1].target.terms — Mouse sonication site not described beyond transducer on depilated head; striatal samples analysed. Target term 'brain' is a placeholder.
  • exposures[0].timing.duty_cycle_pct — Continuous wave; duty cycle not stated so left null.